Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines.

medRxiv : the preprint server for health sciences·2026
Same author

Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus Vaccine.

bioRxiv : the preprint server for biology·2026
Same author

Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines.

bioRxiv : the preprint server for biology·2026
Same author

Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing.

iScience·2026
Same author

A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.

Open forum infectious diseases·2026
Same author

Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancy.

The Journal of infectious diseases·2026

Related Experiment Video

Updated: Mar 13, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.9K

Class II-Restricted CD8s: New Lessons Violate Old Paradigms.

Stephen A Migueles1, Mark Connors1

  • 1HIV-Specific Immunity Section, Laboratory of Immunoregulation, Division of Intramural Research NIAID, Bethesda, MD 20892, USA.

Immunity
|October 21, 2016
PubMed
Summary

Virus-specific CD8+ T cells recognizing MHC class II peptides were found in some HIV patients. This challenges previous understandings of T cell responses in human immunodeficiency virus infection.

More Related Videos

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
15:42

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers

Published on: March 6, 2009

22.3K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.6K

Related Experiment Videos

Last Updated: Mar 13, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.9K
Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
15:42

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers

Published on: March 6, 2009

22.3K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.6K

Area of Science:

  • Immunology
  • Virology
  • Cellular Biology

Background:

  • CD8+ T cells typically recognize peptides presented by MHC class I molecules.
  • Previous research in macaque models showed CD8+ T cells recognizing MHC class II molecules in the context of SIV vaccination.
  • The presence and function of such cells in human viral infections remained largely unexplored.

Purpose of the Study:

  • To investigate the existence of virus-specific CD8+ T cells restricted by MHC class II molecules in HIV-infected patients.
  • To determine if findings from SIV vaccine models in macaques are applicable to human HIV infection.

Main Methods:

  • Analysis of peripheral blood mononuclear cells (PBMCs) from HIV-infected individuals.
  • Immune cell phenotyping and functional assays to identify and characterize CD8+ T cells.
  • Investigation of T cell receptor (TCR) interactions with viral peptides presented by MHC class II molecules.

Main Results:

  • Identification of virus-specific CD8+ T cells that recognize peptides presented by MHC class II molecules in a subset of HIV-infected patients.
  • Demonstration that these cells exhibit cytotoxic activity against infected cells.
  • Confirmation that these CD8+ T cells are distinct from classical MHC class I-restricted CD8+ T cells.

Conclusions:

  • Virus-specific CD8+ T cells restricted by MHC class II molecules can be present during chronic HIV infection.
  • These findings suggest a broader role for CD8+ T cell immunity in HIV infection than previously appreciated.
  • Further research into the therapeutic potential of targeting these MHC class II-restricted CD8+ T cells is warranted.